Clinicopathological Profile of Head and Neck Cancers in Army Hospital of Nepal
1 other identifier
observational
76
1 country
1
Brief Summary
This is a observational study conducted at the department of Ear ,Nose and Throat -Head and Neck Surgery (ENT-HNS) of Shree Birendra Hospital ,a tertiary health care centre of Nepal. Head and Neck cancers are the sixth most common cancer in the world. Data was collected from the medical records of Head and Neck Cancer patients who underwent treatment between May 2022 to April 2023.The main aim of the study was to know about the common cancers of head and neck region and their distribution according to the site. Also to know the stage of the presentation with treatment modalities in the tertiary health care centre of Nepal.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2023
CompletedFirst Submitted
Initial submission to the registry
November 21, 2023
CompletedFirst Posted
Study publicly available on registry
November 30, 2023
CompletedNovember 30, 2023
November 1, 2023
12 months
November 21, 2023
November 21, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Age - wise Distribution of Head and Neck Cancers (HNCs)
Age - wise Distribution of Head and Neck Cancer
1 year
: Distribution of HNCs according to subsite
Distribution of Head and Neck Cancers according to the subsite
1 year
Histopathology of HNCs
Histopathology of Head and Neck Cancer
1 year
Tumor, Nodes, Metastasis (TNM) staging of HNC
Staging at presentation of Head and Neck Cancer
1 year
Treatment provided to HNC patients
Treatment Modalities of Head and Neck Cancer
1 year
Eligibility Criteria
Study population was selected from the tertiary care centre of Nepal.
You may qualify if:
- All histologically proven cases of head and neck region.
You may not qualify if:
- Patient's record with incomplete data.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shree Birendra Hospital
Kathmandu, 977, Nepal
Related Publications (1)
Chin D, Boyle GM, Porceddu S, Theile DR, Parsons PG, Coman WB. Head and neck cancer: past, present and future. Expert Rev Anticancer Ther. 2006 Jul;6(7):1111-8. doi: 10.1586/14737140.6.7.1111.
PMID: 16831082BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Reeba Karki, MS
Shree Birendra Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Intern Doctor
Study Record Dates
First Submitted
November 21, 2023
First Posted
November 30, 2023
Study Start
May 1, 2022
Primary Completion
April 30, 2023
Study Completion
April 30, 2023
Last Updated
November 30, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share
There is no plan to share the individual participant data to protect the privacy of the participants.